Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain

• Published in: Protein expression and purification Vol. 104; pp. 57 - 64
• Main Authors: Gao, Ning, McLeod, Sarah M., Hajec, Laurel, Olivier, Nelson B., Lahiri, Sushmita D., Bryan Prince, D., Thresher, Jason, Ross, Philip L., Whiteaker, James D., Doig, Peter, Li, Amanda Haixi, Hill, Pamela J., Cornebise, Mark, Reck, Folkert, Hale, Michael R.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2014
• Subjects: acrB; Amidohydrolases - antagonists & inhibitors; Amidohydrolases - genetics; Amidohydrolases - metabolism; Bacterial Proteins - antagonists & inhibitors; Bacterial Proteins - genetics; Bacterial Proteins - metabolism; Catalysis; Chromatography, Liquid; Crystallization; Crystallography, X-Ray; Escherichia coli; Escherichia coli Proteins - genetics; Gene Expression; Inhibitor; LpxC; Mass Spectrometry; Multidrug Resistance-Associated Proteins - genetics; Protein Conformation; Protein expression; Protein purification; Pseudomonas aeruginosa; Pseudomonas aeruginosa - enzymology; Zinc - chemistry; Zinc - metabolism; Protein expression; Inhibitor; LpxC; Protein purification; Crystallization; acrB
• ISSN: 1046-5928; 1096-0279
• DOI: 10.1016/j.pep.2014.09.006

•P. aeruginosa LpxC forms soluble aggregates when expressed in E. coli.•Expression in the presence of LpxC inhibitors greatly increases LpxC solubility.•Expression in an efflux pump-deficient E. coli strain reduces compound requirements.•High-quality crystal structures of LpxC complexed with inhibitors were obtained. In Gram-negative bacteria, the cell wall is surrounded by an outer membrane, the outer leaflet of which is comprised of charged lipopolysaccharide (LPS) molecules. Lipid A, a component of LPS, anchors this molecule to the outer membrane. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) is a zinc-dependent metalloamidase that catalyzes the first committed step of biosynthesis of Lipid A, making it a promising target for antibiotic therapy. Formation of soluble aggregates of Pseudomonas aeruginosa LpxC protein when overexpressed in Escherichia coli has limited the availability of high quality protein for X-ray crystallography. Expression of LpxC in the presence of an inhibitor dramatically increased protein solubility, shortened crystallization time and led to a high-resolution crystal structure of LpxC bound to the inhibitor. However, this approach required large amounts of compound, restricting its use. To reduce the amount of compound needed, an overexpression strain of E. coli was created lacking acrB, a critical component of the major efflux pump. By overexpressing LpxC in the efflux deficient strain in the presence of LpxC inhibitors, several structures of P. aeruginosa LpxC in complex with different compounds were solved to accelerate structure-based drug design.